Pathological responses and survival outcomes in patients with locally advanced breast cancer after neoadjuvant chemotherapy: a single-institute experience.
Kyrillus S ShohdyDoaa S AlmeldinMadonna A FekryMahmoud A IsmailNedal A AboElmaarefEsraa G ElSadanyBaher M HamzaFatma H El-ShorbagyAhmad S AliHanaa AttiaLoay KassemPublished in: Journal of the Egyptian National Cancer Institute (2021)
Luminal tumors still draw benefit from neoadjuvant chemotherapy in terms of clinical response and breast conservative surgery. Treatment escalation to those who did not achieve pCR requires more investigation, given a higher recurrence rate in real-world experience.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- rectal cancer
- lymph node
- sentinel lymph node
- squamous cell carcinoma
- radiation therapy
- minimally invasive
- phase ii study
- coronary artery bypass
- open label
- coronary artery disease
- clinical trial
- combination therapy
- free survival
- young adults
- acute coronary syndrome
- study protocol